New FDA Biosimilar Guidances and Proposed Rule

Published date12 December 2018
Law FirmGoodwin
Subject MatterFDA,FDCA,Public Health Service Act,Biosimilars,New Guidance,Comment Period,Pharmaceutical Industry,Proposed Rules

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT